These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 19929464)
1. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Pasquet S; Sovalat H; Hénon P; Bischoff N; Arkam Y; Ojeda-Uribe M; Bouar Rl; Rimelen V; Brink I; Dallemand R; Monassier JP Cytotherapy; 2009; 11(8):1002-15. PubMed ID: 19929464 [TBL] [Abstract][Full Text] [Related]
2. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells. Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532 [TBL] [Abstract][Full Text] [Related]
3. The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease. Mozid AM; Jones D; Arnous S; Saunders N; Wragg A; Martin J; Agrawal S; Mathur A Stem Cells Dev; 2013 Jan; 22(2):216-23. PubMed ID: 22834565 [TBL] [Abstract][Full Text] [Related]
4. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869 [TBL] [Abstract][Full Text] [Related]
5. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor. Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278 [TBL] [Abstract][Full Text] [Related]
6. Human hematopoietic stem/progenitor-enriched CD34(+) cells are mobilized into peripheral blood during stress related to ischemic stroke or acute myocardial infarction. Paczkowska E; Larysz B; Rzeuski R; Karbicka A; Jałowiński R; Kornacewicz-Jach Z; Ratajczak MZ; Machaliński B Eur J Haematol; 2005 Dec; 75(6):461-7. PubMed ID: 16313257 [TBL] [Abstract][Full Text] [Related]
7. Direct cardiac injection of G-CSF mobilized bone-marrow stem-cells improves ventricular function in old myocardial infarction. Archundia A; Aceves JL; López-Hernández M; Alvarado M; Rodriguez E; Díaz Quiroz G; Páez A; Rojas FM; Montaño LF Life Sci; 2005 Dec; 78(3):279-83. PubMed ID: 16183081 [TBL] [Abstract][Full Text] [Related]
8. CD34+ cell adhesion molecule profiles differ between patients mobilized with granulocyte-colony-stimulating factor alone and chemotherapy followed by granulocyte-colony-stimulating factor. Ford CD; Greenwood J; Anderson J; Snow G; Petersen FB Transfusion; 2006 Feb; 46(2):193-8. PubMed ID: 16441594 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesis. Körbling M; Reuben JM; Gao H; Lee BN; Harris DM; Cogdell D; Giralt SA; Khouri IF; Saliba RM; Champlin RE; Zhang W; Estrov Z Transfusion; 2006 Oct; 46(10):1795-802. PubMed ID: 17002637 [TBL] [Abstract][Full Text] [Related]
10. Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Wojakowski W; Tendera M; Michałowska A; Majka M; Kucia M; Maślankiewicz K; Wyderka R; Ochała A; Ratajczak MZ Circulation; 2004 Nov; 110(20):3213-20. PubMed ID: 15533859 [TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: final results from the G-CSF-STEMI (Granulocyte Colony-Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial. Engelmann MG; Theiss HD; Hennig-Theiss C; Huber A; Wintersperger BJ; Werle-Ruedinger AE; Schoenberg SO; Steinbeck G; Franz WM J Am Coll Cardiol; 2006 Oct; 48(8):1712-21. PubMed ID: 17045910 [TBL] [Abstract][Full Text] [Related]
12. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Gordon MY; Levicar N; Pai M; Bachellier P; Dimarakis I; Al-Allaf F; M'Hamdi H; Thalji T; Welsh JP; Marley SB; Davies J; Dazzi F; Marelli-Berg F; Tait P; Playford R; Jiao L; Jensen S; Nicholls JP; Ayav A; Nohandani M; Farzaneh F; Gaken J; Dodge R; Alison M; Apperley JF; Lechler R; Habib NA Stem Cells; 2006 Jul; 24(7):1822-30. PubMed ID: 16556705 [TBL] [Abstract][Full Text] [Related]
13. Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction. Cheng Z; Liu X; Ou L; Zhou X; Liu Y; Jia X; Zhang J; Li Y; Kong D Cardiovasc Drugs Ther; 2008 Oct; 22(5):363-71. PubMed ID: 18461431 [TBL] [Abstract][Full Text] [Related]
14. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Kang HJ; Lee HY; Na SH; Chang SA; Park KW; Kim HK; Kim SY; Chang HJ; Lee W; Kang WJ; Koo BK; Kim YJ; Lee DS; Sohn DW; Han KS; Oh BH; Park YB; Kim HS Circulation; 2006 Jul; 114(1 Suppl):I145-51. PubMed ID: 16820564 [TBL] [Abstract][Full Text] [Related]
15. Single leukapheresis products collected from healthy donors after the administration of granulocyte colony-stimulating factor contain ten-fold higher numbers of long-term reconstituting hematopoietic progenitor cells than conventional bone marrow allografts. Theilgaard-Mönch K; Raaschou-Jensen K; Andersen H; Russell CA; Vindeløv L; Jacobsen N; Dickmeiss E Bone Marrow Transplant; 1999 Feb; 23(3):243-9. PubMed ID: 10084255 [TBL] [Abstract][Full Text] [Related]
16. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma. Lemoli RM; Cavo M; Fortuna A J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709 [TBL] [Abstract][Full Text] [Related]
17. Biological characterization of CD34+ cells mobilized into peripheral blood. Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction. Delgaudine M; Gothot A; Beguin Y Cytotherapy; 2010 Nov; 12(7):909-18. PubMed ID: 20230223 [TBL] [Abstract][Full Text] [Related]
19. Quantitation of primitive and lineage-committed progenitors in mobilized peripheral blood for prediction of platelet recovery post autologous transplant. Hogge DE; Lambie K; Sutherland HJ; Benny WB; Dalal B; Currie C; Barnett MJ; Eaves AC; Eaves CJ Bone Marrow Transplant; 2000 Mar; 25(6):589-98. PubMed ID: 10734292 [TBL] [Abstract][Full Text] [Related]
20. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells . Haas R; Murea S Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]